Matsuo T, Kadowaki S, Okada K, Matsuo O
Department of Internal Medicine, Hyogo Prefectural Awaji Hospital, Sumoto, Japan.
J Diabet Complications. 1990 Jul-Sep;4(3):119-21. doi: 10.1016/0891-6632(90)90051-6.
The activity of free tissue plasminogen activator (f-tPA) and plasminogen activator inhibitor (PAI) in the plasma of 82 noninsulin-dependent diabetics (NIDDM) was measured by bioimmunoassay of the euglobulin fraction obtained from the plasma, and the levels were compared with those of age- and gender-matched normal subjects. Comparison of these levels in both groups revealed that the f-tPA activity tended to be lower in NIDDM than in the controls, although the differences were not significant. Normal activity of PAI was seen, but f-tPA in NIDDM, when accompanied by macroangiopathy such as ischemic heart disease, was significantly depressed. When glycosylated hemoglobin levels were in excess of 10%, the f-tPA activity was significantly decreased, but no reduction was found in PAI activity as compared with controls. When NIDDM is associated with either macroangiopathy or high glycosylated hemoglobin levels, a decreased f-tPA activity, rather than an increased PAI activity, may contribute to the development of a defective fibrinolytic state.
通过对从血浆中获得的优球蛋白组分进行生物免疫测定,检测了82例非胰岛素依赖型糖尿病患者(NIDDM)血浆中游离组织型纤溶酶原激活剂(f-tPA)和纤溶酶原激活剂抑制剂(PAI)的活性,并将其水平与年龄和性别匹配的正常受试者进行比较。两组这些水平的比较显示,NIDDM患者的f-tPA活性虽低于对照组,但差异无统计学意义。PAI活性正常,但NIDDM患者伴有缺血性心脏病等大血管病变时,f-tPA显著降低。当糖化血红蛋白水平超过10%时,f-tPA活性显著降低,但与对照组相比,PAI活性未见降低。当NIDDM伴有大血管病变或高糖化血红蛋白水平时,f-tPA活性降低而非PAI活性增加可能导致纤溶状态异常的发生。